Thursday, November 1, 2012

FDA reports voluntary recall of all Ameridose drug products

The U.S. Food and Drug Administration announced today (October 31) that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation. Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo disclaimer icon. A complete list of all products subject to this recall can be accessed at www.ameridose.com disclaimer icon.

For more information on this voluntary recall, please click here for the complete FDA news release.